MedTrace Logo

Prevalence of Acute Hepatic Porphyria

NCT04923516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-01-28

No results posted yet for this study

Summary

To determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent for a suggestive clinical picture with a first negative etiological assessment.

Conditions

  • Acute Hepatic Porphyria

Interventions

OTHER

Dosage of Delta-aminolevulinic acid and Porphobilinogen

Results of dosages of Delta-aminolevulinic acid and Porphobilinogen which are performed in accordance with the current practice will be recorded

Sponsors & Collaborators

  • Association pour la Recherche en Medecine Interne

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2023-12-29
Completion
2023-12-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04923516 on ClinicalTrials.gov